Your browser doesn't support javascript.
loading
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.
Girardin, François R; Cohen, Karen; Schwenkglenks, Matthias; Durand-Zaleski, Isabelle.
Afiliación
  • Girardin FR; Division of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Faculty of Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Cohen K; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Schwenkglenks M; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
  • Durand-Zaleski I; Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, Zürich, Switzerland.
Front Pharmacol ; 14: 1210002, 2023.
Article en En | MEDLINE | ID: mdl-37261286
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Health_technology_assessment Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Health_technology_assessment Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article